Business academics have been trying to uncover empirical evidence around how financing decisions are linked with technology. After all, the business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.
0
min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.